NDC 46066-754 - Sevoflurane
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 46066-754
- Package NDCs from labels
- 46066-754-04
- Manufacturer
- Aspen Veterinary Resources, Ltd. | Halocarbon Life Sciences, LLC | Pharmasol
- Effective date
- 2020-09-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sevoflurane Inhalation Anesthetic For Use in Dogs | Aspen Veterinary Resources, Ltd. | Halocarbon Life Sciences, LLC | Pharmasol | 2020-09-25 | PRESCRIPTION ANIMAL DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sevoflurane | SEVOFLURANE | Shandong New Time Pharmaceutical Co., Ltd. | c808afe1-ebf1-44cf-9187-09656331bff5 | 2026-06-02 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane, (Volatile for Inhalation) | SEVOFLURANE | Mullan Pharmaceutical Inc. | 0ca6da3a-6a18-400d-8c49-08a5534b025f | 2026-03-23 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane | SEVOFLURANE | Halocarbon Life Sciences, LLC | bdde7502-6218-401c-9a4f-dd3bc3a80f72 | 2025-12-18 | Warnings, Adverse reactions | 38LVP0K73A |
| Sojourn | SEVOFLURANE | Piramal Critical Care Inc | fedfd1db-7e32-44b2-89e9-7bb00ee6810d | 2025-12-01 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane | SEVOFLURANE | Piramal Critical Care Inc | b23e14d7-9e5b-13f4-e053-2a95a90a0cde | 2025-12-01 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane | SEVOFLURANE | Bryant Ranch Prepack | 06b9f724-6425-4976-93eb-b9ca343ef5cf | 2025-11-06 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane | SEVOFLURANE | Piramal Critical Care Inc | 3dbab949-6ab7-4040-9c81-314e5bb61d41 | 2025-10-03 | Warnings, Adverse reactions | 38LVP0K73A |
| SEVOFLURANE | SEVOFLURANE | Baxter Healthcare Corporation | 22700993-851a-48aa-941e-1d2b6b04081f | 2025-04-30 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane | SEVOFLURANE | Baxter Healthcare Company | ea8bf997-2c71-4014-b18d-4f7ab45dfa19 | 2025-03-28 | Warnings, Adverse reactions | 38LVP0K73A |
| Ultane | SEVOFLURANE | AbbVie Inc. | c9aa6489-5a36-44ed-9512-b996833d82f7 | 2025-02-12 | Warnings, Adverse reactions | 38LVP0K73A |
| Ultane | SEVOFLURANE | AbbVie Inc. | 4c6e76bc-c964-4955-e0a3-511d3386a9cc | 2025-01-13 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane | SEVOFLURANE | Lannett Company, Inc. | 5bfc1cef-824d-4ebf-bb4d-fbc46c0abb79 | 2023-09-19 | Warnings, Adverse reactions | 38LVP0K73A |
| Sevoflurane | SEVOFLURANE | Sandoz Inc. | 8604f245-fa99-4092-9042-058aa42e0b74 | 2022-11-08 | Warnings, Adverse reactions | 38LVP0K73A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.